Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enzastaurin plus R-GEMOX in Relapsed DLBCL
NCT00436280Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2007
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of enzastaurin in diffuse large B-cell lymphoma (DLBCL), sponsored by Eli Lilly and Company. Started Feb 2007; status: completed.
02
Drugs
enzastaurin
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00436280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00436280.